MACHADO, Pedro M.; BAROHN, Richard J.; MCDERMOTT, Michael P.; SUNDGREEN, Claus; BLAETTLER, Thomas; HANNA, Michael G.; DIMACHKIE, Mazen. Design and rationale for a randomized, double-blind, placebo-controlled Phase 2/3 trial of oral arimoclomol in inclusion body myositis. RRNMF Neuromuscular Journal, [S. l.], v. 5, n. 2, 2024. DOI: 10.17161/rrnmf.v4i5.16244. Disponível em: https://journals.ku.edu/rrnmf/article/view/16244. Acesso em: 16 apr. 2025.